Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | LEGH | IBP |
|---|---|---|
| Price | $28.31 | $180.16 |
| Change today | ▲ 0.07% | ▼ 2.30% |
| Market cap | $673.30M | $4.79B |
| Return, 3 months | +7.5% | -17.9% |
| Return, year to date | +45.0% | -29.7% |
| Return, 1 year | +24.4% | -24.9% |
| P/E (TTM) | 13.2 | 19.4 |
| P/B | 1.2 | 7.5 |
| P/E percentile vs own 5y | 90th | 43rd |
| Dividend yield | – | 1.84% |
| Revenue growth (YoY, latest qtr) | +32.3% | +2.3% |
| Net profit growth (YoY) | +59.8% | -5.9% |
| Gross margin | 48.8% | 33.6% |
| Operating margin | 32.8% | 12.4% |
| Net margin | 28.6% | 8.5% |
| Return on equity | 9.5% | 38.5% |
| Analyst target vs. price | – | +37.3% |
| Analyst buy share | – | 33% |
| RSI (14) | 47 | 31 |
| 30-day volatility | 20.0% | 41.1% |
| Max drawdown, 1 year | -31.7% | -45.8% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
